Elevated myxovirus resistance protein‐1 (MxA) levels accurately distinguish COVID‐19 infections from bacterial infections and noninfectious diagnoses in patients with suspected COVID‐19 infection in the emergency department. The gene discussed is MX1; the disease is bacterial infectious disease.